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To this date, states with access to vaccines against the new coronavirus are
focusing exclusively on inoculating people under their jurisdiction. This process
has been accurately described as “vaccine nationalism”. So far, a legal basis for
an explicit human right to the distribution of vaccines is not codified in any treaty.
However, the right to health and the right to enjoy the benefits of scientific progress
and its applications are well established in international law. As such, they play
a key role in the context of developing “new” human rights – particularly through
their interconnectedness. In the present article, I will explore to what extent these
two rights can work towards establishing a “new” human right to the distribution of
vaccines.
Access to Vaccines as an Integral Part of the Right to Health?
The right to health is codified, inter alia, in Art. 12 of the International Covenant
on Economic, Social and Cultural Rights (ICESCR). Among other obligations, this
provision requires the ICESCR’s 171 state parties to respect, protect and fulfil the
right to health by implementing health policies. The “right to health” is a misleading
expression, since Art. 12 ICESCR does not include a right to “be healthy”. Rather,
it obliges state parties to take all necessary steps towards guaranteeing the
“enjoyment of the highest attainable standard of physical and mental health”.
Art. 12 ICESCR does not expressly mention the distribution of vaccines or the
distribution and access of medical resources. Yet, it does refer to “the prevention,
treatment and control of epidemic […] diseases” (Art. 12(2) lit. c ICESCR). In
order to better understand its precise meaning, the General Comments (GCs) and
statements of the Committee on Economic, Social and Cultural Rights (Committee)
can be used as a means of interpretation. While not legally binding, they provide
important guidance as authoritative interpretations of the ICESCR. In GC No. 14 on
the right to health, the Committee recognised the need to include new determinants
of health in the interpretation of Art. 12 ICESCR, such as the distribution of
resources and formerly unknown diseases (para. 10). In 2020, GC No. 25 provided
further guidance by linking the right to health with the right to enjoy the benefits
of scientific progress (Art. 15(1) lit. b ICESCR). According to GC No. 25 para. 67,
this right incorporates the duty of states to establish new medical applications.
In the same paragraph, the Committee also explicitly stated that the availability
and distribution of vaccines as essential medical products to combat diseases is
covered by its interpretation of the right to health. Recently, this interpretation was
reaffirmed by the Committee in its “Statement on universal affordable vaccination
for COVID-19, international cooperation and intellectual property” (Statement)
on 12th March 2021.
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Counterbalancing International Cooperation and Domestic Preference
Since this new reading by the Committee covers the distribution of vaccines, one
might ask whether states are only obliged to fulfil this right towards people under
their jurisdiction, or vis-à-vis other state parties of the ICESCR. In general, there is
no jurisdiction clause which limits the obligations of the ICESCR to people under
a state’s jurisdiction. According to the doctrinal consensus and the Committee,
the states parties’ “obligation to fulfil” the right to health relates firstly to national
measures. Examples of such national measures include the implementation of
national health policies, programmes to fight infectious diseases, and the just
distribution of medical resources within the respective state (GC No. 14 para. 36).
This resembles with Art. 15(1) lit. b ICESCR, since its core obligation relates to
national frameworks and action plans (GC No. 25 para. 52). Consequently, the act of
prioritising people under its jurisdiction is not only common in law but corresponds to
well-established the reading of international human rights obligations (see e.g. here
and here).
At the same time, states must also consider their obligations towards the
international community. Indeed, the right to health and the right to enjoy the benefits
of scientific progress both comprise an obligation of international assistance and
cooperation. International cooperation is an obligation that can be derived from
various legal sources, such as Art. 15(4) and Art. 2(1) ICESCR as well as Art. 1(3)
of the UN Charter (UNCh). The duty to cooperate does not only refer to the action
between states; it also obliges them to cooperate with organs of the UN. Cooperation
in the field of health is especially highlighted by Art. 56 and Art. 55(1) lit. b UNCh
and the non-binding Alma-Ata Declaration on primary health care of 1978. The
latter aims to even out the large differences between the overall health status in the
Global North and South by urging states to cooperate. However, it can be criticised
of being overly broad and infeasible. Nevertheless, as stated by the Committee,
international cooperation is especially needed because of the existing inequality
between states (GC No. 25 para. 79, Statement para. 2). The Committee also
highlighted the special cooperation duty during a pandemic between states and
towards the WHO, referring specifically to the need to share knowledge about
vaccines (GC No. 25 para. 82). According to the legally non-binding Maastricht
Principles on Extraterritorial Obligations of 2011, which are principles concerning
the economic, social and cultural human rights, the states’ duty to cooperate also
covers technical and financial assistance (para. 33) aimed at realising human
rights universally (para. 8). Such a broad obligation remains highly controversial.
Nonetheless, one could consider applying the no-harm principle (discussed here)
in this context, prohibiting states to harm one another by stock-piling vaccines.
Accordingly, a violation of the no-harm principle by a state would already occur if the
number of vaccines exceeded the amount needed for protecting its population.
GC No. 14 para. 39 mentions three prerequisites for a state’s obligation to facilitate
access, hence distribute resources to other states: The help must be necessary,
the provision of resources must be possible, and the resources concerned must be
available. Without doubt, the distribution of vaccines is necessary to those states
that are not able to establish a vaccination regime. However, both the provision and
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the availability are questionable during the COVID-19 pandemic. The provision of
vaccines requires an effective medical infrastructure such as adequate refrigeration
facilities. Further, their availability is an obstacle too, since to this date, there is a
severe scarcity of vaccines. One could argue that the two conditions (possibility and
availability) have not been met as required by the Committee, which itself envisages
problems in this regard (Statement paras. 1, 10). But does that mean that no such
obligation applies at all?
According to GC No. 25 para. 70, states are obliged to make their best
scientific progress accessible to everyone to enjoy the highest realisable
standard of health. To this end, states must use the maximum of their available
resources (Art. 2(1) ICESCR). This primarily addresses the Global North due to its
economically advanced position. According to the Committee, they have a special
responsibility to help during a health crisis even if the prerequisites mentioned
above are not fulfilled. The Committee even argues that states would otherwise
violate their extraterritorial obligations (Statement para. 4). If the provision of
vaccines towards states in the Global South is not feasible, financial support to
individual states will have considerable effect (GC No. 25 para. 67, GC No. 14
para. 40, Statement para. 6). It could either be directed towards individual states
or initiatives such as “COVID-19 Vaccines Global Access” (COVAX). Another way
to make vaccines more available for all is by sharing their “recipe“. However, this
raises additional questions concerning intellectual property rights in the field of
health (discussed in Statement paras. 7-13 and here). The Committee calls for
a supportive function of intellectual property rights in the context of the access
to medical resources, especially towards states of the Global South (GC No. 25
paras. 69, 83). Even further, it argues that states must prevent intellectual property
rights, as a “social product”, from being detrimental to economic, social and cultural
human rights (Statement para. 7). In total, there are many ideas on how states could
address such a distribution.
The Emerging Human Right to the Distribution of Vaccines
The distribution of vaccines is crucial to fight the coronavirus and its mutations. So
far, states have refused to accept a positive extraterritorial obligation in the context
of the right to health and the right to enjoy the benefits of scientific progress and
its applications. While it is lawful and reasonable to concentrate on the vaccination
of people under a state’s jurisdiction first, the international community must face
the reality that the COVID-19 pandemic can only be overcome if the majority of the
world’s population has been vaccinated. If states want to prevent the global spread
of the coronavirus and in particular the development of its mutations, the new and
combined reading of Art. 12(2) lit. c and Art. 15(1) lit. b ICESCR by the Committee
can guide states in light of the prerequisites discussed above: necessity, possibility,
and availability. Tackling the COVID-19 pandemic definitely demands the best efforts
of all states – especially of the Global North. The aim must be to counteract the
widening inequality between states, particularly in light of the obligation to cooperate.
While there is no explicit legal basis for a human right to the distribution of vaccines
quite yet, the COVID-19 pandemic could well serve as a catalyst for defining the
emerging human right to the distribution of vaccines.
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